Clinical Trials Browser

Solid Tumor, Adult × Other solid neoplasm × Clear all

NCT00571389 2026-03-18

A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.

Other solid neoplasm

Solid Tumor, Adult

NCT05223608 2026-03-18

ImmuCCo

Phase NA Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05689853 2026-03-18

Study of AK119 Combined With AK112 in Patients With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06391918 2026-03-13

Phase 1 Study of GEN2 in Patients With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04928508 2026-03-05

Okgyn1

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07137195 2026-02-27

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Hebei)

Phase NA Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04219254 2026-02-25

A Study of BI-1206 in Combination With Pembrolizumab in Subjects With Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05381909 2026-02-20

A Study of BGB-24714 as Monotherapy and With Combination Therapies in Participants With Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT06265688 2026-02-20

First In Human Study of CX-2051 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06772090 2026-02-03

Probiotic Supplementation During Cytotoxic Chemotherapy for Solid Tumor Malignancies

Phase NA Not yet recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06397963 2026-01-26

Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients With Solid Tumours

Phase NA Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT07153094 2026-01-16

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Shenzhen)

Phase NA Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07294872 2026-01-16

A Study of TIL in Advanced Solid Tumors (CZ)

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04725474 2026-01-12

GDFATHER

Phase 1/2 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07159828 2026-01-09

A Study to Assess AXN-2510 Treatment in Adult Patients With Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06265727 2026-01-08

A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT07152353 2026-01-07

Clinical Trial of the Safety and Efficacy of IBA Proton Therapy System PROTEUS® PLUS (Sichuan)

Phase NA Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05307874 2025-12-24

EVICTION-2

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06554795 2025-12-23

First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06383884 2025-12-15

Patritumab Deruxtecan in Patients With Solid Tumor Harboring an NRG1 Fusion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06977737 2025-12-08

ATTEST

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05582850 2025-08-28

EPRAD

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06088004 2025-08-22

Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT02220556 2025-08-08

CTC-CEC-ADN

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03410121 2025-08-05

PACPAC-EPOC

Phase NA Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03772561 2025-07-22

MEDIPAC

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT03990233 2025-06-26

A Trial of BI 765063 Monotherapy and in Combination With BI 754091 in Patients With Advanced Solid Tumours

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT04899505 2025-05-16

ODORAJA

Other solid neoplasm

Solid Tumor, Adult

NCT06462716 2025-04-13

A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05620472 2025-04-09

Molecular Imaging of EpCAM Receptors Using [99mTc]Tc(CO)3-(HE)3-Ec1

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06895733 2025-03-26

Study of Pazopanib Combined With Palbociclib for Refractory Solid Tumors With Co-amplified in the 11q13(FGF3/4/19/CCND1)

Phase 1/2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT04585035 2025-03-18

Study to Evaluate D-1553 in Subjects With Solid Tumors

Phase 1/2 Active not recruiting

Other solid neoplasmThoracic

Solid Tumor, Adult

NCT04597541 2025-03-10

A Study of AK112 for Advanced Solid Tumors

Phase 1/2 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06032845 2025-02-27

CASTLE-11

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05559541 2025-02-19

Study of AK119 Combined With AK104 in Patients With Advanced Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04643574 2025-02-14

NeoTIL in Advanced Solid Tumors

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05601219 2025-01-28

A Phase 1 Study of ADA-011 for Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT06524804 2024-12-18

A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors

Phase 1/2 Terminated

Other solid neoplasm

Solid Tumor, Adult

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06003621 2024-11-15

MoST-TAP

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT05763004 2024-10-08

A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination with Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Solid Tumor, Adult

NCT03302325 2024-09-19

Circulating Tumor DNA As Liquid Biopsy in Patients with Stage IV Solid Tumors, a Feasibility Study At MUSC HCC

Other solid neoplasm

Solid Tumor, Adult

NCT03516123 2024-09-19

A Study of CS3006 in Subjects with Locally Advanced or Metastatic Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT03523819 2024-09-19

A Study of CS1002 in Subjects with Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT05117177 2024-09-19

New Formulation Study of Inupadenant (EOS100850) in Patients with Cancer

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

NCT06462794 2024-09-19

First In Human Study of CX-801 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT06292845 2024-08-28

SprayDye

Phase NA Recruiting

Other solid neoplasm

Solid Tumor, Adult

NCT03355066 2024-08-09

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor, Adult